Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Summary of Restricted Stock and Restricted Stock Units Activity

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2023:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2022	669,673	$	22.00
Shares granted	831,746	11.83
Vested shares	(319,225)	22.03
Shares forfeited	(130,030)	17.53
Non vested, December 31, 2023	1,052,164	$	14.74

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2024:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2023	1,052,164	$	14.74
Shares granted	595,976	10.71
Vested shares	(475,116)	14.89
Shares forfeited	(66,768)	14.60
Non vested, December 31, 2024	1,106,256	$	12.63

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2025:

	Number of Shares	Weighted Average Grant Price and Fair Value
Non vested, December 31, 2024	1,106,256	$	12.63
Shares granted	548,171	22.91
Vested shares	(517,471)	13.50
Shares forfeited	(210,194)	16.64
Non vested, December 31, 2025	926,762	$	17.01

Summary of Status of Stock Incentive Plans and Changes During Periods

The table below sets forth stock option activity for the year ended December 31, 2023:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2022	133,588	$	21.04	8.09	$	37
Options granted	33,762	6.71		10	$	—
Awards exercised	—	—
Options forfeited	(3,968)	26.20
Outstanding, December 31, 2023	163,382	$	17.95	7.73	$	119
Exercisable, December 31, 2023	83,644	$	23.16	6.78	$	—

The table below sets forth stock option activity for the year ended December 31, 2024:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2023	163,382	$	17.95	7.73	$	119
Options granted	—	—		—	$	—
Awards exercised	(5,796)	11.60
Options forfeited	(4,616)	5.36
Outstanding, December 31, 2024	152,970	$	18.57	6.64	$	799
Exercisable, December 31, 2024	116,332	$	21.10	6.25	$	397

The table below sets forth stock option activity for the year ended December 31, 2025:

	Number of Options	Weighted Average Exercise Price		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
					(in thousands)
Outstanding, December 31, 2024	152,970	$	18.57	6.64	$	799
Options granted	—	—		—	$	—
Awards exercised	(75,715)	18.81
Options forfeited	(1,600)	32.33
Outstanding, December 31, 2025	75,655	$	18.04	5.07	$	1,495
Exercisable, December 31, 2025	66,710	$	19.52	4.78	$	1,220

Summary of Fair Value at the Date of Grant

	Year Ended December 31,
	2023
Expected volatility	53.50		%
Expected dividends	—		%
Expected term, in years	10
Risk-free interest rate	3.49		%
Weighted-average fair value of options granted during the year	$	4.44

Summary of Stock-Based Compensation

For the years ended December 31, 2023, 2024, and 2025, the Company recognized stock-based compensation expense as follows (in thousands):

	Year Ended December 31,
	2023		2024		2025
Instructional costs and services	$	895	$	808	$	770
Selling and promotional	490		562		759
General and administrative	6,355		6,298		6,823
Total stock-based compensation expense	$	7,740	$	7,668	$	8,352